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ABSTRACT 
 
Obesity impairs skeletal muscle maintenance and regeneration, a condition that can 
progressively lead to muscle loss, but the mechanisms behind it are unknown. Muscle is 
primarily composed of multinucleated cells called myotubes which are derived by the 
fusion of mononucleated myocytes. A key mediator in this process is the cellular fusion 
protein syncytin-1. This led to the hypothesis that syncytin-1 could be decreased in the 
muscle of obese/insulin resistant individuals. In contrast, it was found that obese/insulin 
resistant subjects had higher syncytin-1 expression in the muscle compared to that of the 
lean subjects. Across the subjects, syncytin-1 correlated significantly with body mass 
index, percent body fat, blood glucose and HbA1c levels, insulin sensitivity and muscle 
protein fractional synthesis rate. The concentrations of specific plasma fatty acids, such as 
the saturated fatty acid (palmitate) and monounsaturated fatty acid (oleate) are known to 
be altered in obese/insulin resistant humans, and also to influence the protein synthesis in 
muscle.  Therefore, it was evaluated that the effects of palmitate and oleate on syncytin-1 
expression, as well as 4E-BP1 phosphorylation, a key mechanism regulating muscle 
protein synthesis in insulin stimulated C2C12 myotubes. The results showed that treatment 
with 20 nM insulin, 300 µM oleate, 300 µM oleate +20 nM insulin and 300 µM palmitate 
+ 300 µM oleate elevated 4E-BP1 phosphorylation. At the same time, 20 nM insulin, 300 
µM palmitate, 300 µM oleate + 20 nM insulin and 300 µM palmitate + 300 µM oleate 
elevated syncytin-1 expression. Insulin stimulated muscle syncytin-1 expression and 4E-
BP1 phosphorylation, and this effect was comparable to that observed in the presence of 
oleate alone. However, the presence of palmitate + oleate diminished the stimulatory effect 
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of insulin on muscle syncytin-1 expression and 4E-BP1 phosphorylation. These findings 
indicate oleate but not palmitate increased total 4E-BP1 phosphorylation regardless of 
insulin and the presence of palmitate in insulin mediated C2C12 cells. The presence of 
palmitate inhibited the upregulation of total 4EB-P1 phosphorylation. Palmitate but not 
oleate increased syncytin-1 expression in insulin mediated C2C12 myotubes. It is possible 
that chronic hyperinsulinemia in obesity and/or elevated levels of fatty acids such as 
palmitate in plasma could have contributed to syncytin-1 overexpression and decreased 
muscle protein fractional synthesis rate in obese/insulin resistant human muscle.  
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CHAPTER 1 
INTRODUCTION: 
Detrimental effects of obesity on skeletal muscle  
Obesity associated with insulin resistance and chronic inflammation is a major 
long-term risk factor for metabolic syndrome conditions such as Type-2 Diabetes (T2D) 
and cardiovascular disease (CVD). Millions of people in the overweight to moderately 
obese population (based on body mass index – BMI) have normal blood glucose 
concentrations but remain undiagnosed as pre-diabetic (Zhang et al., 2009). This 
population ultimately ends up showing the complications of T2D such as atherosclerosis, 
neuropathy, nephropathy, retinopathy, and foot ulcers, requiring immediate and expensive 
medical care. Thus, understanding the metabolic features of obesity and translating these 
findings to therapeutic approaches is of key importance for decreasing the burden of 
metabolic syndrome.  
 
The prominent features of obesity associated metabolic syndrome is the lack of 
glucose and lipid homeostasis with subsequent elevation in their levels in blood, leading to 
further pathological complications in multiple tissues such as cardiomyocytes, endothelial 
cells (Clark et al., 2003). The main site for maintaining glucose homeostasis in the body is 
muscle, which is known to be altered in obesity leading to decreased glucose uptake. 
Obesity associated specific alterations in skeletal muscle metabolism are documented as 
impaired insulin stimulated protein synthesis (Tardif et al., 2014). Decrease in muscle 
protein synthesis correlates with increase body fat accumulation with age despite 
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maintenance of stable body weight (Abdelhafiz & Sinclair, 2016). A progression of this 
condition leads to decline in muscle mass (known as sarcopenia) in elderly, and is termed 
as “sarcopenic obesity” (Roubenoff, 2000). Since sarcopenia impacts muscle movement 
function and associated energy expenditure, it leads to a sedentary lifestyle leading to 
further body fat accumulation thus forming a vicious cycle of obesity and sarcopenia which 
reinforce each other (Roubenoff, 2000).  
 
The exact reason behind the decrease in muscle protein synthesis in obesity are 
unknown. However what is known that when resistance training is performed during a 
period of energy restriction in obese older individuals, muscle protein synthesis was 
conserved (Smith & Villareal, 2012). Since resistance training is associated with increased 
myogenesis (Frese et al., 2015), it will be an ideal strategy to overcome “sarcopenic 
obesity”. However, what are the mechanisms that impair myogenesis in obesity remains 
unknown. In this perspective understanding the correlation and regulation of myogenesis 
mediators in obesity could provide novel lifestyle or therapeutic strategies towards 
addressing sarcopenic obesity and insulin sensitivity. 
 
Muscle overview and myogenesis 
Muscle is one of the soft tissues found in animals. Cytoskeletal filaments such as 
actin and myosin make up a predominant portion of muscle cells which regulate contraction 
by changing the length as well as the shapes of the cell by sliding past one another. Muscle 
exhibit characteristics such as excitability (responding to neural stimuli), contractibility 
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(able to shorten in length), extensibility (able to increase in length) and elasticity (able to 
return to its original shape and size after contraction/extension). It also performs key 
functions in the body such as facilitating motion, maintenance of posture, thermogenesis 
and glycogen storage (Jensen, Rustad, Kolnes, & Lai, 2011). To carry out these wide-
ranging tasks, muscles have developed in to two broad categories: voluntary and 
involuntary muscles. Voluntary muscles include skeletal muscles which are attached to 
bones and help in the movement of the skeletal structure based on specific voluntary neural 
inputs. Involuntary muscles such as smooth muscles in the walls of blood vessels, intestine 
and cardiac muscles carry out their function independently of voluntary inputs.  
 
Muscle cells are developed from their precursor cells, called myocytes, which 
differentiate into long, tubular cells called myotubes by a process known as myogenesis. 
Alignment of multiple myotubes gives rise to a muscle fiber that comprises the muscle 
tissue. During the process of myogenesis, the myocytes fuse together to form myotubes in 
voluntary skeletal muscles, but not in involuntary muscles. Undifferentiated myocytes 
remain within the muscle fiber as myosatellite cells and undergo myogenesis in the 
presence of specific stimuli such as exercise or muscle injury (Wang & Rudnicki, 2011).  
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Figure 1. A schematic depiction of the anatomy of a muscle fiber. Muscle cells are 
multinucleated and are made up of thick myosin and thin actin filaments that are arranged 
in a specific pattern. 
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Syncytin and sarcopenic obesity 
Skeletal muscles constitutes a predominant site of glucose utilization next to brain 
(DeFronzo & Tripathy, 2009). Considering their capacity for high uptake of glucose, 
skeletal muscle inevitably plays a key role in glucose homeostasis of the body, and 
depending on their active participation in glucose uptake which is mediated by insulin 
signaling in skeletal muscles. In addition, the process of myogenesis is also mediated by 
insulin signaling (Al-Khalili, Krämer, Wretenberg, & Krook, 2004). Cell fusion of 
myoblasts is a critical step during skeletal muscle differentiation (myogenesis), 
maintenance and repair (Yablonka-Reuveni, 2011). The cell fusion event during skeletal 
muscle myogenesis requires the presence of fusogenic agent that brings the cell membranes 
of the two fusing cells in contact. A protein known as syncytin-1 performs this function 
and is found in three isoforms syncytin-1, 2 and 3 (Bjerregard, Ziomkiewicz, Schulz, & 
Larsson, 2014). This protein is derived from the human endogenous retroviral (HERV)-
derived gene (Mi et al., 2000). It was originally a virus encoded protein that helped in the 
fusion of the viral membrane with host cell membrane which was incorporated into human 
genome to end up serving the fusion events between the host cell with the loss of viral 
genetic components (Sapir et al., 2013). Syncytin-1 and 3 alone play a role in cell fusion 
within which syncytin-1 has a dominant role. This was evident when treatment of 
myoblasts with anti-syncytin-1 resulted in loss of cell fusion (Frese et al., 2015). In 
addition, the major sites of syncytin-1 expression are placental syncytiotrophoblasts, 
multinucleate cells from fetal trophoblasts (Mi et al., 2000), differentiating osteoclasts (Søe 
et al., 2011), and cancer cells (Maliniemi et al., 2013). Regarding syncytiotrophoblasts, the 
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fusion of cells lining the placenta prevents a direct exposure of the foetus inside the 
placenta from the immune system of the mother (Mi et al., 2000). Though a large body of 
literature is available on the levels and regulation of myogenic mediators such as myosin 
(Egan & Zierath, 2013), myogenin (Fu et al., 2016), desmin, alpha-actinin-2 (Houweling 
et al., 2017) in obesity, similar data on syncytin-1 and its regulation in skeletal muscle of 
obese/insulin resistant people is lacking. Moreover, syncytin-1 may be of relevance to 
understanding muscle protein synthesis via two possible modes 1) its receptor Neutral 
amino acid transporter B(0) (ASCT2) which is a key essential amino acid transporter in the 
cells (Sugimoto, Sugimoto, Bernstein, Jinno, & Schust, 2013) and 2) Increased syncytin-1 
expression has been shown to mediate endoplasmic reticulum (ER) stress response under 
multiple sclerosis (Antony et al., 2007). Since amino acid starvation is a direct signal for 
ER stress response via elongation initiation factor – 2 alpha (eIF-2α) to decrease protein 
synthesis (Krishnamoorthy & Pavitt, 2001), exploring syncytin-1 expression and 
correlating with protein synthesis in lean and obese/insulin resistant subjects could provide 
insights into the downstream effects of syncytin-1. Considering its prime importance in 
muscle cell fusion under exercise activities such as cycling (Frese et al., 2015) and loss of  
myotubes by treatment of fatty acids in vitro (Yang et al., 2013), understanding the exact 
correlation of syncytin-1 with obesity and its regulation by insulin and fatty acids could 
provide novel insights into the development and treatment of sarcopenic obesity. 
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Figure 2. Synctin-1’s expression is essential for the fusion of myotubes from myoblasts. 
Exercise induced increase in syncytin-1’s expression in muscle which increased myotube 
formation in healthy humans. Differentiation of the myoblasts invitro also showed that 
syncytin-1 increased in expression during myotube formation. Adapted with permission 
from previous report (Frese et al., 2015).   
 
Insulin regulation of muscle protein synthesis  
Insulin stimulates protein synthesis in multiple cell types including skeletal muscle. 
Insulin mediated-stimulation involves two types of effects: rapid and long term. The rapid 
effect is mediated by eIFs (eukaryotic initiation factors) and eEFs (eukaryotic elongation 
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factors) which are activated by the insulin. The long term effects involve an increase in 
ribosomal contents by the insulin (Proud, 2006). Protein synthesis activation by insulin is 
primarily through phosphoinositide 3-kinase - Akt axis. Downstream of this axis, 
regulation by protein synthesis happens in two phases. In one case, PKB phosphorylates 
and inhibits glycogen synthase kinase 3 which in turn is a mediator of eIF2B dependent 
inhibition on global protein synthesis. In the second case, PKB activates mTOR 
(mammalian target of rapamycin) by phosphorylating and relieving the inhibitory effect of 
TSC1/2 (tuberous sclerosis complex 1/2) on mTOR complex 1 (mTORC1). Translation 
initiation and elongation is controlled by mTORC1 via 4E-BP1 phosphorylation on 
threonine 37/46 position to activate protein synthesis (Proud, 2006). 
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Figure 3. Overview of insulin regulation of protein synthesis. 
 
Role of fatty acids in muscle protein synthesis 
Fatty acids have been shown to influence insulin sensitivity and protein synthesis 
in a manner depending on their saturation and chain length (Kalhan, 2009). The fatty-acid 
composition of membranes is a cellular factor that has been shown to influence the action 
of insulin in cells (Weijers, 2012). Studies of insulin sensitivity indicate that increasing the 
content of polyunsaturated fatty acids within cell membranes in cultured cells increases 
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membrane fluidity (Brand et al., 2010), the number of insulin receptors (Le Marchand-
Brustel et al., 2003), and the action of insulin (Manco, Calvani, & Mingrone, 2004). When 
the saturated fatty acids concentration in the membrane increase there is a converse effect 
(Grunfeld et al., 1981). Mechanistically, long-chain polyunsaturated fatty acids within 
membrane phospholipids have been shown to influence insulin receptor signaling and 
glucose transporter translocation, through effects on the physical properties of their 
surrounding lipid environment (Weijers, 2012).  
 
The fatty acid composition in the body fat stored in adipocytes in the form of 
triglycerides in lipid drops consists of (C16) palmitate synthesized via fatty acid synthase 
complex in the cytosol and its extension to (C18) stearate mediated by the elongase isoform 
- ELOVL6 in the endoplasmic reticulum followed by its desaturation to (C18:1) oleate (Shi 
et al., 2017). Among palmitate, stearate and oleate, oleate constitutes the major fraction of 
triglyceride composition in lipid drops of adipocytes followed by palmitate (Listenberger 
et al., 2003). Though an effect of chain elongation and desaturation in membrane fluidity 
and resulting changes in cellular signaling is known, knowledge of the functional 
significance of these different fatty acids in circulation on syncytin-1 mediated myogenesis 
is lacking. This is critically applicable in cases where there is increased circulation of free 
fatty acids released from adipocyte lipolysis in obesity (Duncan, Ahmadian, Jaworski, 
Sarkadi-Nagy, & Sul, 2007). A previous study from our lab showed that circulating non-
esterified fatty acids (NEFA) extracted from the serum of obese resulted in decreased 
translation efficiency of muscle β1-F1-ATPase compared to NEFA from lean subject 
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suggesting the key role played by circulating fatty acid on protein synthesis (Tran et al., 
2016). Thus, understanding the functional significance of palmitate and oleate on syncytin-
1 levels and linking with insulin mediated protein synthesis mediators in muscle cells could 
provide novel insights into their regulation in sarcopenic obesity. 
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Objectives of the work  
Human study: 
Skeletal muscle cells are specifically evolved cells to enact physical movement in 
animals and they do so by utilizing glucose as a primary fuel source. To enact their 
function, the muscles need to increase their protein content of cytoskeletal proteins such as 
myosin, myogenin and a fusion of myocytes to myotubes mediated by syncytin-1. Thus, a 
combined effect of muscle protein synthesis and muscle fusion by syncytin-1 is required 
for the homeostatic function of muscle. Since defective muscle function is known to be 
associated with sarcopenic obesity, it can be hypothesized that either muscle protein 
synthesis or syncytin-1 alone or both are down regulated. Current knowledge on this aspect 
of skeletal muscle in obesity is lacking. Hence the first objective of the study was designed 
as follows: 
 
Objective 1: To determine the expression of fusogenic protein syncytin-1 and the rate of 
protein synthesis in skeletal muscle in lean and obese/insulin resistant human subjects. 
Hypothesis 1: It was hypothesized that expression of fusogenic protein synctyin-1 will be 
decreased in obese/insulin resistant human subjects. There will be a positive correlation 
between syncytin-1 expression and the rate of protein synthesis in obese/insulin resistant 
human subjects.  
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Cell culture study: 
Previous evidence has shown the influence of fatty acids such as palmitate and 
oleate on myogenesis and insulin signaling cascade mediated muscle protein synthesis in 
a C2C12 myotube model of skeletal muscle in vitro (Kwon & Querfurth, 2015). However, 
evidence on the effects of fatty acids on syncytin-1 expression or the regulation of protein 
synthesis under physiological concentrations of insulin and/or fatty acids is lacking. 
Considering that alterations in myogenesis mediated by syncytin-1 may have a crucial role 
in defective insulin mediated muscle protein synthesis in obesity, we hypothesized that 
fatty acids such as palmitate and oleate will have a regulatory effect of syncytin-1 
expression. 
 
Objective 2: To determine the effect of insulin and fatty acids on insulin-stimulated 
syncytin-1 and 4E-BP1 expression in C2C12 myotubes. 
Hypothesis 2: It was hypothesized that insulin will increase syncytin-1 expression and 4E-
BP1 phosphorylation, and that concurrent treatment with fatty acids will inhibit this effect. 
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CHAPTER 2 
RESULTS AIM 1: CORRELATION BETWEEN THE EXPRESSION OF SYNCYTIN-
1 AND MUSCLE PROTEIN SYNTHESIS IN OBESITY IN HUMAN SUBJECTS 
Considering the critical function of syncytin-1 in myogenesis and the loss of muscle 
function in obesity, we evaluated the levels of syncytin-1 in lean and obese/insulin resistant 
human subjects using western blot analysis and correlated with the overall muscle protein 
synthesis rate. The human subjects were classified as lean and obese based on their Body 
Mass Index (BMI) and body fat percentage. Glucose and glycated hemoglobin (Hb-A1c) 
measurements were done in the blood and insulin levels were measured in the serum 
samples of the subjects and, the MATSUDA index (DeFronzo & Matsuda, 2010) was 
calculated. In addition, fractional synthesis rate (FSR) measurements were done to 
determine the protein synthesis in vivo using labelled leucine tracer (Tran, Masters, Roust, 
& Katsanos, 2015). The characteristics of the human subjects are listed in Table 1, and 
blood/-serum biochemical parameters and muscle protein synthesis are listed in Table 2.  
 
SUBJECT CHARACTERISTICS: 
 
Parameters Lean Obese 
Total (n) 6 8 
Male/Female 2/4 5/3 
Age (years) 30 ± 8 34 ± 9 
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Table 1. Characteristics of lean and obese subjects included for the study.  
 
 
BLOOD AND SERUM PARAMETERS: 
 
Parameters   Lean Obese p-value 
BMI (Kg/m2) 22.5 ± 2.9 33.6 ± 2.3 <0.001 
BF (%) 24.7 ± 7.3 33.3 ± 5.5 <0.05 
Total Mass (Kg)  66.9 ± 15.4 98.6 ± 12.2 <0.001 
Lean Mass (Kg) 50.5 ± 5.1 67.0 ± 3.0 <0.05 
Triglyceride (mg/dL) 70.8 ± 11.0 191.6 ± 42.1 <0.05 
Total NEFA (mmol/L) 0.39 ± 0.1 0.41 ± 0.1 >0.05 
Total Palmitate (μmol/L) 129.6 ± 17.3 120.0 ± 14.1 >0.05 
Total Oleate (μmol/L) 184.9 ± 29.8 161.2 ± 29.4 >0.05 
Glucose (mg/dL) 85.6 ± 3.0 101.8 ± 14.9 <0.05 
HbA1c (%) 5.3 ± 0.2 5.7 ± 0.4 <0.05 
Insulin (uIU/mL) 3.9 ± 1.2 10.8 ± 5.2 <0.01 
Matsuda (ISI) 8.8 ± 2.5 3.5 ± 1.6 <0.001 
 
Table 2. Blood and serum biochemical parameters of the lean and obese human subjects. 
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CORRLATIONS TABLE 
 
Parameters Pearson correlation coefficient (r) p-Value 
BMI (Kg/m2) 0.65 <0.01 
BF (%) 0.57 <0.05 
Total Mass (Kg) 0.47 >0.05 
Lean Mass (Kg) 0.23 >0.05 
Triglyceride (mg/dL) 0.36 >0.05 
Total NEFA (mmol/L) 0.09 >0.05 
Total Palmitate (μmol/L) 0.10 >0.05 
Total Oleate (μmol/L) 0.04 >0.05 
Glucose (mg/dL) 0.55 <0.05 
HbA1c (%) 0.61 <0.05 
Insulin (uIU /mL) 0.37 >0.05 
Matsuda (ISI) - 0.54 <0.05 
 
Table 3. Correlation between syncytin-1 expression and blood and plasma biochemical 
parameters.  
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Western blot analysis showing significant increase in syncytin-1 levels in the obese/insulin 
resistant subjects (Figure 4). 
 
  
 
Figure 4. Western blot analysis of syncytin-1 in skeletal muscle of lean and obese/insulin 
resistant subjects. A) Western blot image of syncytin-1 and housekeeping gene GAPDH, 
which was used as loading control. B) Average densitometry values of syncytin-1/GAPDH 
determined in skeletal muscle of the lean and obese/insulin resistant subjects represented 
in a bar graph. 
 
 
18 
 
There was inverse correlation between syncytin-1 levels and muscle protein synthesis of 
skeletal muscle in the human subjects (Figure 5). In addition, a significant correlation was 
observed for syncytin-1 expression with BMI, percent body fat, blood glucose 
concentration, HbA1c, and MATSUDA insulin sensitivity index (Table 2).  
 
 
 
 
 
 
Figure 5. The graph shows significant correlation between syncytin-1’s expression and 
fractional synthesis rate (FSR) of muscle proteins across lean and obese/insulin resistant 
subjects.  
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The findings from the human studies showed an increase in syncytin-1 level with decrease 
in muscle protein synthesis in obese/insulin resistant humans. Since insulin and fatty acids 
have been known to influence muscle protein synthesis, we sought to understand their 
effects on syncytin-1 using an in vitro model (following chapter). 
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CHAPTER 3 
RESULTS AIM 2: EFFECT OF FATTY ACIDS IN THE PRESENCE AND ABSENCE 
OF INSULIN ON THE REGULATION OF SYNCYTIN-1 EXPRESSION AND 4E-BP1 
PHOSPHORYLATION AND EXPRESSION 
To understand the link between increased syncytin-1 expression and obesity in 
muscles, we undertook an in vitro study using C2C12 mouse muscle cell line. The cells 
were cultured as myoblasts and differentiated into myotubes in the presence of 2% horse 
serum (Figure 6). The differentiation of myoblasts to myotubes has been shown to express 
syncytin-1 protein which mediate the fusion of cells (Frese et al., 2015). Since the 
progression of obesity has its greatest impact on differentiated muscles which in turn leads 
to sarcopenia (Dorrens & Rennie, 2003), we investigated the treatment of differentiated 
C2C12 cells with key fatty acids palmitate and oleate in the presence and absence of insulin 
(20 nM). We evaluated the levels of protein synthesis marker 4E-BP1 phosphorylation and 
myotube fusion marker syncytin-1 expression in vitro. The immune-blot densitometry 
levels were normalized to myosin heavy chain (MYH) expression as loading control as 
GAPDH showed a variation between treatments (Figure 7). In the absence of insulin, 300 
µM oleate treatment and a combination of 300 µM oleate + 300 µM palmitate treatment 
produced an increase in total 4E-BP1 phosphorylation compared to control (Figure 9). In 
the presence of 20 nM insulin by itself produced a significant increase in total 4E-BP1 
phosphorylation which was maintained in the presence of 300 µM oleate (Figure 9). The 
increase in total protein 4E-BP1 levels was observed only in the case of 20 nM insulin, 300 
µM palmitate + 20 nM insulin and 300 µM oleate + 300 µM palmitate treatments (Figure 
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10). However, there was no significant differences in the ratio of phosphorylated 4E-BP1 
to total 4E-BP1 (Figure 11).   
 
Analysis of syncytin-1 expression in differentiated C2C12 myotubes in the absence 
of insulin showed a stimulatory effect of 300 µM palmitate and 300 µM oleate + 300 µM 
palmitate on syncytin-1 expression (Figure 8). 20 nM insulin treatment alone also produced 
a significant up regulation of syncytin-1 expression which was maintained in the presence 
of 300 µM oleate (Figure 8).  
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Figure 6. C2C12 cells images taken at 40X magnification, after treatment of cells with A) 
No insulin B) 20 nM Insulin C) 300 µM Palmitate D) 300 µM Palmitate + 20 nM Insulin 
E) 300 µM Oleate F) 300 µM Oleate + 20 nM Insulin G) 300 µM Oleate + 300 µM 
Palmitate H) 300 µM Oleate + 300 µM Palmitate + 20 nM Insulin for 24 hours. The bar in 
the figure indicates 1 mm. 
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Figure 7. Western blot bands and densitometry analysis of GAPDH/Myosin Heavy chain 
showing the variation of GAPDH expression with the treatment of fatty acids and insulin 
on C2C12 cells.   
 
24 
 
 
 
 
Figure 8. Western blot bands images and densitometry analysis of syncytin-1/MYH. 
Syncytin-1 expression in differentiated C2C12 myotubes showed a stimulatory effect of 
insulin, palmitate and in the combined treatment of oleate + insulin and palmitate + oleate.  
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Figure 9. Western blot bands and densitometry analysis of total 4EBP1 
phosphorylation/MYH showing insulin has a stimulatory effect on total 4E-BP1 
phosphorylation. The presence of oleate alone or along with insulin/palmitate also 
produced a significant increase in total 4E-BP1 phosphorylation compared to control.  
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Figure 10. Western blot bands and densitometry analysis showing the levels of total 
protein 4E-BP1 were altered between the treatments in the same manner as total 4E-BP1 
phosphorylation. 
27 
 
 
Figure 11. Western blot bands and densitometry analysis showing the levels of 4E-BP1 
phosphorylation levels to total 4E-BP1. There were no significant differences between 
groups. 
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CHAPTER 4 
DISCUSSION 
Human study: 
The study aimed to determine the effects of obesity on the regulation of the 
fusogenic protein syncytin-1 expression. In our studies with lean and obese/insulin resistant 
human subjects we found an inverse correlation between syncytin-1 expression and muscle 
protein synthesis in humans. Interestingly, this was contrary to our hypothesis, considering 
the myogenic role of syncytin-1 in the fusion of myoblasts to myotubes we hypothesized a 
decrease in syncytin-1 in obesity which could directly explain sarcopenia in obesity. 
Increased syncytin-1 expression in obesity could rather signify two possibilities: first 
possibility is an alteration of amino acid transport which could be mediated by syncytin-1 
receptor ASCT2. ASCT2 is a key amino acid transporter (Sugimoto et al., 2013) of 
essential amino acids such as leucine and isoleucine whose alterations could result in 
GCN2-eIF-2α dependent inhibition of protein synthesis in the presence of amino acid 
deprivation (Krishnamoorthy & Pavitt, 2001).  Second possibility could be an increase in 
ER stress through NO synthase expression. In the astrocytes, NO synthase expression, is 
mediated by overexpression of old astrocyte specifically induced substance (OASIS) in 
multiple sclerosis (MS) which has shown to increase syncytin-1 expression (Antony et al., 
2007). 
 
Though it is known ASCT2 is a receptor for syncytin-1, it might be a possibility 
that increased levels of syncytin-1, as observed in obesity, could block amino acid transport 
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by ASCT2. Considering the stimulatory effect of amino acids such as leucine in facilitating 
muscle protein synthesis (Wilson et al., 2010), the blocking of amino acid transport by 
ASCT2 in the presence of elevated syncytin-1 (Frese et al., 2015) could offer a direct 
explanation for the decreased muscle protein synthesis as observed in obese/insulin 
resistant humans via GCN2-eIF2α mediated signaling (Krishnamoorthy & Pavitt, 2001). 
However, prior studies in our lab found that eIF2α phosphorylation (not shown here) was 
not affected in muscle of obese/insulin resistant humans, casting doubts on this possibility.  
 
Considering the second possibility, higher syncytin-1 expression has been linked in 
the brain of individuals with MS (Antony et al., 2007). It has been shown that increased 
syncytin-1 expression was correlated with increased expression of endoplasmic stress 
mediator, old astrocyte specifically induced substance (OASIS) in MS brains. The 
overexpression of OASIS in cultured astrocytes have been shown to increase inducible NO 
synthase expression and concurrently downregulate ASCT-1, a receptor for syncytin-1 and 
a neutral amino acid transporter. siRNA mediated suppression of syncytin-1 expression 
prevented the negative effects on ASCT-1 (Antony et al., 2007). Considering the potential 
role of amino acid availability and ER stress in regulating protein synthesis via mTOR and 
eIF-2α signaling, a combined effect of syncytin-1 expression on amino acid transport and 
ER stress is possible and may account for the negative correlation between protein 
synthesis and syncytin-1 expression. 
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Cell culture study: 
The in vitro findings on the C2C12 muscle cell line in the absence of insulin show 
a positive impact of oleate, either alone or in combination with palmitate, on total 4E-BP1 
phosphorylation dependent protein synthesis. Interestingly, palmitate did not have a 
significant effect on total 4E-BP1 phosphorylation. This contrasts the findings by Kwon 
and Querfurth, 2015, in which 300 µM palmitate decreased total 4E-BP1 phosphorylation 
and was rescued by 300 µM oleate in C2C12 myotubes. The differences in the outcome 
may be due to the experimental design in our study which includes an additional treatment 
of 100 nM insulin stimulation for 15 minutes in all the groups before lysis of cells to record 
the insulin stimulated response. As expected, 20 nM insulin alone was sufficient to increase 
total 4E-BP1 phosphorylation which was maintained only in the presence of 300 µM 
oleate. This positive effect of 300 µM oleate, rather than palmitate, on insulin mediated 
total 4E-BP1 phosphorylation is an original finding with respect to insulin-fatty acid 
interaction in regulating protein synthesis signaling. 
 
Regulation of syncytin-1 by fatty acids in the absence of insulin showed that 300 
µM palmitate and a combination of 300 µM palmitate + 300 µM oleate produced an 
increase in the expression of syncytin-1 indicating a stimulatory effect. However, in the 
presence of 20 nM insulin, only 300 µM oleate produced a stimulatory effect. Interestingly, 
the combination of 300 µM palmitate + 300 µM oleate in the presence of 20 nM insulin 
negated the stimulatory effect of insulin on syncytin-1 expression as well as total 4E-BP1 
phosphorylation. Moreover, in the absence of insulin though 300 µM palmitate produced 
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an increase in syncytin-1 expression it did not produce an increase in total 4E-BP1 
phosphorylation as done by insulin. On the contrary, 300 µM oleate in the absence of 
insulin produced similar effects on syncytin-1 expression and total 4E-BP1 
phosphorylation as done by insulin.  The study by Kwon and Querfurth, 2015 indicate that 
neither palmitate nor oleate produced significant differences in mTOR phosphorylation but 
only had significant effects downstream of mTOR via p70S6K and 4E-BP1 
phosphorylation. The only existing evidence from the literature that supports our findings 
on insulin’s regulation of syncytin-1 in skeletal muscle is from a study which showed that 
insulin-like growth factor (IGF) signaling has been shown to activate syncytin-1 expression 
in cancer cells via AKT-mTOR-Estrogen Receptor α (ERα) pathway (Strissel et al., 2008). 
These findings implicate that insulin’s regulation over syncytin-1 and 4E-BP1 follow a 
common axis up to a certain point (possibly mTOR) and branch out beyond it. Moreover, 
in the presence of 20 nM insulin, signaling that branches towards 4E-BP1 can be prevented 
from stimulation by 300 µM palmitate either alone or in combination with 300 µM oleate 
but not by 300 µM oleate alone. The signaling that branches towards syncytin-1 expression 
requires a combination of 300 µM palmitate + 300 µM oleate to negate the stimulatory 
effect of 20 nM insulin. These results highlight a novel differential regulation of insulin 
signaling cascade towards 4E-BP1 and syncytin-1 via palmitate and oleate. This suggests 
an additional regulation of syncytin-1 in addition to its known regulation by glucagon-
cAMP-PKA cascade (Knerr et al., 2005). In the light of in vitro findings, the elevated 
syncytin-1 in obesity in vivo could be correlated with MATSUDA index (Table 2), which 
is a measures of insulin sensitivity. Moreover, the obese/insulin resistant subjects showed 
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an increased trend of insulin levels (although not significant – p<0.05) but might have been 
enough to have an impact on syncytin-1 expression and its associated correlation with 
muscle protein synthesis. In this perspective, chronic hyperinsulinemia and/or the levels of 
palmitate in the blood might have contributed to the decreased muscle protein synthesis. 
An additional perspective of the results from human and in vitro studies is that exercise has 
been shown to elevate the levels of syncytin-1 (Frese et al., 2015) and decrease in muscle 
protein synthesis with reduction in total 4E-BP1 phosphorylation (Dreyer et al., 2006). 
Interestingly, the elevation of syncytin-1 is a transient response during the differentiation 
of myoblasts into myotubes (Frese et al., 2015) analogous the inhibition of 4E-BP1 to 
conserve the ATP consumed towards protein synthesis (Dreyer et al., 2006). This 
physiological response to exercise fits with the action of palmitate which has been shown 
to lower the ATP supply reserved for protein synthesis (Nisr & Affourtit, 2016) and thereby 
might explain its inhibitory effect of total 4E-BP1 phosphorylation but stimulatory effect 
on syncytin-1 expression.  
 
Further studies on this interplay between fatty acids and insulin signaling cascade 
in regulating syncytin-1 expression and total 4E-BP1 phosphorylation (Figure 13) are 
required.  
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Figure 12. Pathway showing the link between insulin like growth factors and syncytin-1, 
and their modifications by fatty acids. Adapted from previous report (Strissel et al., 
2008).   
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Figure 13. A potential model regulating syncytin-1 and 4E-BP1 through fatty acids and 
insulin.  
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Conclusion 
Our studies show that increased syncytin-1 expression correlates with decreased 
muscle protein synthesis in obese/insulin resistant humans. Furthermore, palmitate/oleate 
differentially regulate insulin’s effect on total 4E-BP1 phosphorylation and syncytin-1 
expression in C2C12 myotubes. Specifically, the insulin signaling cascade that branches 
towards 4E-BP1 can be inhibited by 300 µM palmitate either alone or in combination with 
300 µM oleate but not by 300 µM oleate alone (all in the presence of 20 nM insulin). 
Whereas, the signaling regulating syncytin-1 expression requires a combination of 300 µM 
palmitate + 300 µM oleate to be inhibited in the presence of 20 nM insulin.  
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CHAPTER 5 
METHODS AND MATERIALS 
Study participants 
Lean (BMI < 25 kg/m2) and obese (BMI >30 kg/m2) subjects were recruited to 
take part in the experimental procedures described below. Initial screening over the 
phone was conducted to determine subjects that were healthy and met the study criteria. 
They were invited to Clinical Studies Infusion Unit (CSIU) in Mayo Clinic in Scottsdale, 
Arizona for further screening. Physical activity was used as a parameter to screen 
subjects and those who were physically active less than two days per week (i.e., 
sedentary individuals) were included in the study. Conditions of heart disease, diabetes, 
liver or kidney disease, elevated blood pressure (chronic, systolic, > 150 mmHg; 
diastolic, >100 mmHg), peripheral vascular disease, smoking, weight-loss regimen 
participation, acute illness, use of nutritional supplements and prescription or over the 
counter medications were used as exclusion criteria. The CSIU was used for screening, 
which included a medical history, electrocardiogram, urine tests, physical exam and 
standard blood chemistry tests. Oral glucose tolerance test (OGTT) was used to 
determine Insulin sensitivity and by calculating the Matsuda insulin-sensitivity index 
(DeFronzo & Matsuda, 2010).  
 
Experimental design 
The participants were informed to avoid any form of exercise, alcohol 
consumption and maintain a regular diet for three days prior to study visits. All the 
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studies were started at ~7:30 am at CSIU, after a 10-h overnight fast, and after verbally 
confirming compliance with the exercise and diet instruction. A catheter was placed into 
an antecubital arm vein for infusion of a stable isotope of a leucine tracer, and another in 
a retrograde fashion in a dorsal hand vein for blood sampling. The heated-hand technique 
was used for blood sampling. Infusion of L- [2,3,3,4,5,5,5,6,6,6-2H10]leucine, 0.15 
μmol∙kg FFM-1∙min-1 (priming dose, 6.4 μmol∙kg FFM-1), was initiated and was 
continued till the end of the study. Synthesis rate of overall muscle protein was 
determined using “d10-to-d9-leucine approach” (Tran et al., 2015) from muscle biopsy 
samples collected at 120 and 300 mins after the start of d-10 leucine infusion. The muscle 
biopsy samples were also used to study relevant markers of protein metabolism (i.e., 
eukaryotic translation initiation factor 4E-binding protein 1) and fusion (i.e., syncytin-1). 
The tissue samples were cleaned of any visible fat and connective tissue and were 
immediately stored in liquid nitrogen. Blood samples were collected at specified time 
points for the determination of d9-leucine enrichment, and as previously described (Tran 
et al., 2015).  
 
Cell culture and differentiation 
 C2C12 mouse myoblasts were grown in growth media containing Dulbecco’s 
Modified Eagle’s Medium (DMEM) with 20 % Fetal Bovine Serum (FBS) and 1 % 
antibiotic- antimycotic. After 95% confluency, cells were differentiated in differentiation 
media containing DMEM with 2% Horse Serum (HS) and 1 % antibiotic- antimycotic for 
5 days till the cells were spindle shaped (Kwon & Querfurth, 2015).   
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Fatty acid preparation and treatment 
 
 200 mM stock solution of palmitate and oleate were prepared using sodium oleate 
and palmitate which were dissolved in 50% ethanol for 30 minutes at 70 °C. 10 % 
solution of fatty acid free- BSA was prepared in Phosphate Buffer Saline (PBS) for 
conjugation purposes. 5mM stock solution of BSA conjugated fatty acid solutions 
(Palmitate and Oleate) were prepared by adding 200 mM stock solution of oleate and 
palmitate in 10 % fatty acid free BSA. Conjugation of the fatty acid and BSA was done at 
37 °C for 1 hour before cell treatment.  
 
C2C12 cells were incubated in Serum free DMEM media for 2 hours before the 
treatment of fatty acids. The conjugated fatty acid – BSA serum was filtered and added to 
serum free DMEM media. Cells were either treated with 300 μm palmitate or 300 μm 
oleate with or without 20 nM insulin for 24 hours. Before harvesting, cells were 
stimulated with 100 nM of insulin for 15 minutes.     
 
Harvesting cells 
 Cells were washed with ice-cold PBS twice after removing the media. 100 μl of 
RIPA (0.5M Tris-HCl, pH 7.4, 1.5M NaCl, 2.5% deoxycholic acid, 10% NP-40, 10mM 
EDTA) lysis buffer with protease and phosphatase inhibitors were added to each well of a 
6-well plate. After 5 minutes, the cells were scrapped off the wells using cell scrappers 
and collected in centrifuge tubes. Cells were centrifuged at 14,000 rpm for 15 minutes in 
39 
 
4oC to collect the supernatant which was used for various assays, such as protein 
estimation and immunoblot analyses. 
 
Protein estimation 
Cell lysate protein concentrations were measured using Coomassie® protein 
assay reagent kit purchased from Pierce Biotechnologies. Briefly, BSA standards were 
used in the concentrations of 0 mg, 0.2 mg, 0.4 mg, 0.6 mg, 0.8 mg, 1 mg for standard 
curve measurements. Cell lysates were diluted in the ratio of 1:40 (Lysate: Mili Q water). 
10 μl of the standard or the unknown lysates were loaded into a 96 well plate. 190 μl of 
the Coomassie Bradford reagent was added and the plate was incubated at room 
temperature for 10 minutes before measuring the absorbance at 595 nm in a 
spectrophotometer.    
 
Human muscle samples 
Approximately 50 mg of muscle sample was homogenized in RIPA (0.5M Tris-
HCl, pH 7.4, 1.5M NaCl, 2.5% deoxycholic acid, 10% NP-40, 10mM EDTA) 
(1mL/100mg tissue) cell lysis buffer with protease and phosphatase inhibitors. The 
homogenate was centrifuged at 14,000 rpm for 15 minutes at 4oC to collect and store the 
supernatant at - 80 °C. 
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Protein immunoblot assays  
A marker related to protein synthesis signaling, 4E-BP1, 4E-BP1 phosphorylation 
and fusion protein marker syncytin-1 were separated using SDS-PAGE and quantified by 
immunoblotting. Specifically, the supernatant was mixed with 2x lamellae buffer and 
boiled at 95 °C for 5 minutes. Protein concentration of ~ 40 ug of muscle homogenate 
and 15 ug of cell lysate from C2C12 myotubes were separated by gel electrophoresis on 
Any kD polyacrylamide gels (Mini-PROTEAN, Bio-Rad Laboratories, Inc.). Biotinylated 
ladder was used as an internal control along with the blue ladder (Precision Plus, Bio-Rad 
Laboratories, Inc.). The gels were transferred onto nitrocellulose membrane in case of 
human muscle homogenates and polyvinylidene difluoride membranes in case of C2C12 
cell lysates for 1 hour at 90 V. After the transfer, membranes were blocked for 1 hour at 
room temperature with TBST + 5% non-fat dry milk (Syncytin-1) or TBST + 5% BSA 
(4ebp1, p-4ebp1). Then the membranes were incubated with primary antibodies at 4oC 
overnight. The primary antibodies used were: anti-4E-BP1 (Cat. # 9452), anti-phospho-
4E-BP1 (Thr37/46) (Cat. # 9459) (all from Cell Signaling Technology) and anti-syncytin-1 
(Cat. # orb100573 from biorbyt). A dilution of 1:1000 was used for all the primary 
antibodies in TBST + 5% BSA except for syncytin-1 which was used at a dilution of 
1:250 in TBST. Anti-GAPDH antibody (Cat. # 600-401-A33, Rockland 
Immunochemicals) was used to quantify GAPDH, which was employed as a loading 
control for human muscle lysate samples. In case of C2C12 lysates, skeletal muscle anti-
myosin (Cat. # 32732, Santa Cruz Biotechnologies) was used to quantify myosin (i.e., 
MYH 1/2/4/6).  
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After the primary antibody incubation, the membranes were washed with TBST 
and incubated with secondary antibody for 1 hour at room temperature. Secondary 
antibodies used were anti-rabbit (Cat. # 205718; Abcam) (for 4E-BP1, 4E-BP-1 
Phosphorylation and GAPDH) and anti-mouse (Cat. # sc-516102; Santa Cruz 
Biotechnology) (for myosin heavy chain) IgG HRP-linked antibodies. A dilution of 
1:2000 (anti-mouse) or 1:5000 (anti-rabbit) in TBST was used as secondary antibodies. 
Excess secondary antibodies were washed with TBST. Clarity™ Western ECL Blotting 
Substrate (Bio-Rad, Hershey, PA) was used to visualize positive bands.  
 
Non-Esterified Fatty Acid Extraction 
Total Non-Esterified Fatty acids (NEFA) were extracted using LC-NH2 Columns 
(Sigma-Aldrich, Hershey, MA). Lipids that were bound to hexane-conditioned LC- NH2 
columns were separated with chloroform. Chloroform was used to wash the columns 
while chloroform/isopropanol (2:1) was used to clear the neutral lipids. 2% acetic 
acid/diethyl ether was used to elute NEFA, and a continuous stream of nitrogen gas was 
used to evaporate solvents. 
 
Calculations  
The precursor-product approach was used in measuring the fractional synthesis 
rate (FSR; %∙hour-1) of overall muscle protein in the human studies, and using the 
calculations described here (Tran et al., 2015).  
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Statistics 
 One-way repeated measures ANOVA was used to compare mean of interest. 
Dunnett’s comparison test was used as a post-hoc test for comparing individual group 
responses with a control. Unpaired t-test was used to compare lean and obese/insulin 
resistant groups. Correlation between muscle protein synthesis and human synctin-1 
densitometry in the human studies was performed using the Pearson Product-Moment 
Correlation. Data are presented as means ± SEM. The level of significance was set at P ≤ 
.05 and all statistical tests were two-sided. Commercially available software (GraphPad 
Prism version 7.03, GraphPad Software, La Jolla, CA) was used in performing statistical 
analyses. 
 
Human studies approval 
All human studies were carried out after obtaining approval by the Institutional 
Review Board at Mayo Clinic. Each study participant was informed of the potential risks 
and benefits associated with participation in the study and written consent was obtained 
prior to inclusion in the study.  
 
Copyright materials 
 Permission was obtained for all copyrighted material (i.e., figures used from the 
work of previously published articles).  
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